ADHD Misnomer: Experts Rethink Core of Attention Disorder

The prevailing understanding of Attention-Deficit/Hyperactivity Disorder (ADHD) may be fundamentally flawed, according to psychiatrist Dr. Awais Aftab. In an article for The New York Times, Aftab posited that the disorder’s name, which emphasizes an "attention deficit," might be a misnomer and that the core issue could lie elsewhere.

Aftab acknowledged the scientific consensus that ADHD is a legitimate condition with effective treatments. However, he suggested that the disorder is less about an individual's inability to pay attention and more about the brain's process of deeming tasks as worthy of focus in the first place. He wrote that stimulants, often used to treat ADHD, enhance the perceived importance of mundane tasks, effectively tricking the brain into assigning greater value to activities like homework or chores.

This perspective is supported by research suggesting that stimulant medications do not directly impact the brain regions associated with attention, as indicated by a study published in Cell. Instead, the effectiveness of these treatments may stem from their ability to increase the brain's assignment of value to tasks, thereby facilitating their completion.

Aftab highlighted that individuals with ADHD can often focus intensely on subjects that interest them, suggesting the primary challenge is not a lack of attention but a difficulty with "sustained engagement." He described attention as the ability to focus on what is relevant in a given moment, while engagement involves maintaining that focus over time.

This viewpoint aligns with that of Clinical Psychologist Thomas Brown, who previously told ADDitude Magazine that ADHD is a cognitive disorder characterized by impairments in the brain's executive functions (EFs). These EFs are the brain's self-management system and include difficulties with task initiation, sustained effort, and impulse control.

Brown contrasted the older model of ADHD as a behavioral disorder with the current understanding, noting that many individuals experience challenges with focusing on necessary tasks and utilizing working memory effectively, rather than significant behavioral issues.

He also pointed out that many aspects of EF dysfunction fall outside the current diagnostic criteria for ADHD as defined in the DSM-5.

Aftab further suggested that individuals may turn to medication to sustain lifestyles that are not inherently suited to their neurobiology. Modern work environments, which often demand multitasking, combined with the diminishing attention spans attributed to widespread mobile phone use, can exacerbate these challenges for those with ADHD.

Despite these conceptual re-evaluations, Aftab emphasized the significant evidence linking ADHD treatment with positive outcomes, including reduced risks of mortality, self-harm, transportation accidents, criminality, and addiction problems.